Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Carrier Global Corporation, on behalf of its Sensitech business, has entered into a definitive agreement to acquire the Monitoring Solutions business of Berlinger & Co. AG, a Swiss family-owned company that specializes in innovative and customized ...
read more
Tuesday, January 14, 2025
Based on the Company’s proprietary 3D genomics platform, integrated with extensive multi-omics analysis, the new 3D Multi-omic offerings provide partners with a powerful end-to-end solution to support and enhance decision-making through every stage ...
read more
Catalent Pharma Solutions, a provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health products and global clinical supply services, has announced the introduction of its Peel-ID™ label, a new standard...
read more
Takeda and Biological E. Limited have entered into a licensing agreement to expedite the development and delivery of affordable combination vaccines.
read more
Albany Molecular Research, a contract research development and manufacturing organization, announced that it is changing its name to Curia, effective July 12, 2021. The new name reinforces the company’s strategic positioning as an end-to-end global ...
read more
Friday, December 14, 2018
Beleave has received its Good Manufacturing Practices (GMP) certification.
read more
Tuesday, October 04, 2016
Ajinomoto Althea, Inc. (“Althea”) announced that a biologics candidate developed by a Japanese global pharmaceutical company and manufactured at Ajinomoto Althea using CORYNEX® Protein Expression System, has entered phase I clinical trials.
read more
The FDA finalized guidance for industry, “Competitive Generic Therapies,” which describes the process that generic drug applicants should follow to request designation of a drug as a CGT and the criteria for that designation.
read more
The FDA issued an EUA for the third vaccine for the prevention of COVID-19.
read more
Monday, December 17, 2018
Proteostasis announced a worldwide, exclusive license agreement with Genentech for rights to potential therapeutic small molecule modulators of an undisclosed target within the proteostasis network.
read more
Tuesday, October 30, 2012
The Aenova Group, one of the leading companies in the global pharmaceutical and healthcare industry, is in the process of taking over the Temmler Group. An agreement was reached today with the previous owners. The purchase price will remain ...
read more
Thursday, November 14, 2024
Aravax announced it has established a UK subsidiary, based on the Oxford Science Park, as the company continues its development into an international leader in food allergies.
read more
Thursday, February 19, 2026
Lonza announced that it has strengthened its Advanced Synthesis offering to increase phase-appropriate support for the discovery and development of antibody-drug conjugates (ADCs) and other bioconjugates.
read more
Wednesday, November 11, 2015
Bespak, a drug delivery device design, development and manufacturing company and Aesica, a global pharmaceutical contract development and manufacturing organization (CDMO), are unveiling a single source supply chain solution for drug delivery ...
read more
CordenPharma and GE Healthcare’s Dharmacon business have entered a collaboration to create an end-to-end solution for oligonucleotide-based drug discovery.
read more